A 2021 review of pulse oximetry accuracy in patients assessed for ECMO. It examines differences in unrecognised hypoxaemia between reported racial groups, the limitations of retrospective data and why skin pigmentation needs more precise investigation than broad racial classifications allow.
JC: More on pulse oximetry and racial bias. St Emlyn’s Read More
Does extracorporeal carbon dioxide removal make lower-volume ventilation safer or more effective? This 2021 review of the REST trial examines 90-day mortality, adverse events and the uncertainty left by early stopping in patients with acute hypoxaemic respiratory failure.
JC: The REST trial. St Emlyn’s Read More
An August 2021 appraisal of the RECOVERY-RS preprint comparing CPAP, high-flow nasal oxygen and conventional oxygen for COVID-19 respiratory failure. It separates the findings on intubation from those on mortality and examines early stopping, crossover and possible treatment-decision bias.
JC: Non-invasive ventilation for COVID 19 patients. The Recovery RS trial. St Emlyn’s Read More
An August 2021 appraisal of therapeutic-dose heparin in hospitalised COVID-19 patients without ICU-level organ support. It examines the multiplatform trial’s benefits, bleeding-risk exclusions and composite outcome, and explains why these findings differ from those in critically ill patients.
JC: Thromboprophylaxis for the non ICU hospitalised COVID-19 patient. St Emlyn’s Read More
Does cooling to 33°C improve outcomes after out-of-hospital cardiac arrest? This 2021 review of TTM2 compares hypothermia with actively managed normothermia, examining survival, neurological outcomes, adverse events and why fever control should not be confused with leaving temperature unmanaged.
JC: The TTM2 trial. Normothermia or hypothermia post cardiac arrest. Read More
What does access to a research paper cost its intended readers? Part two of this series explores purchasing power, publication fees and barriers faced in lower-income countries, then considers green open access, self-archiving and preprints as routes to wider dissemination.
Equitable publishing part 2: Access rules Read More
Choosing a journal means thinking beyond impact factors. Part one of this series asks who needs your research, how regional readership and access costs affect its reach, and how authors can consider audiences in low- and middle-income countries when deciding where to publish.
Equitable publishing part 1: Appraising an audience Read More
Who gets the opportunity to become an author? Part three of the equitable publishing series explores fair authorship, mentorship and sponsorship, with practical ways to support junior researchers and widen opportunities beyond the colleagues already in our immediate networks.
Equitable publishing part 3: Author, mentor, sponsor, replay Read More
